; and (C) manufacturers of such drugs or biologicals reimburse pharmacies for any difference described in subparagraph (B)(ii) with respect to drugs or biologicals of the manufacturer that are dispensed to such individuals. (2) Condition of coverage under Medicare During the period described in subsection (a), no coverage may be provided under part B or D of title XVIII of the Social Security Act ( 42 U.S.C. 1395j et seq., 1395w–101 et seq.) with respect to a drug or biological of a manufacturer if the manufacturer does not enter into an agreement with the Secretary to carry out the requirements applicable with respect to such manufacturers under this subsection. (3) Requirement for participating pharmacies During the period described in subsection (a), a prescription drug plan under part D of title XVIII of the Social Security Act ( 42 U.S.C. 1395w–101 et seq.) may not contract with a pharmacy if the pharmacy does not enter into an agreement with the Secretary to carry out the requirements applicable with respect to pharmacies under this subsection. (f) Other definitions (1) Public or private health insurance plan (A) In general The term public or private health insurance plan means any of the following: (i) A group health plan, or group health insurance coverage, as such terms are defined in section 2791 of the Public Health Service Act ( 42 U.S.C. 300gg–91 ). (ii) A qualified health plan, as defined in section 1301 of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18021 ). (iii) Subject to subparagraph (B), any health insurance coverage (other than a plan described in clause (ii)) offered in the individual market, as such terms are defined in section 2791 of the Public Health Service Act, including any short-term limited duration insurance. (iv) A health plan offered under chapter 89 of title 5, United States Code. (v) A Federal health care program (as defined under section 1128B(f) of the Social Security Act (42 U.S.C. 1320a–7b(f))), including— (I) health benefits furnished under the TRICARE